DUBLIN, Oct. 20, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/hqlltm/2016_emerging) has announced the addition of the "2016 Emerging Strategies for the US Hospital Tumor Marker Testing Market" report to their offering.
This new report contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market testing market, including:
Companies Mentioned
- Abbott- Affymetrix- Beckman Coulter/Danaher- Becton Dickinson- bioMerieux- Bio-Rad- Cepheid- Diamedix- DiaSorin- Eiken Chemical- Elitech Group- Enzo Biochem- Fujirebio- Grifols- Hologic/Gen-Probe- ID Biomedical/GSK- Kreatech/Leica- Lonza- Ortho-Clinical Diagnostics- Qiagen- Roche- Scienion- Sequenom- SeraCare- Siemens- Takara Bio- Thermo Fisher/Life Technology- Wallac/PE- Wako
For more information visit http://www.researchandmarkets.com/research/hqlltm/2016_emerging
Media Contact:
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article